Herrmann Ken bought AKTS
July 17, 2026 · Form 4 insider transaction
Herrmann Ken bought 3,065 shares of Aktis Oncology, Inc. at $0.08 per share, a transaction worth $245.20. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,065
Price
$0.08
Total value
$245.20
InsiderHerrmann Ken
RoleDirector
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 17, 2026
Filing dateJuly 20, 2026
Shares owned after3,065
OwnershipDirect
10b5-1 planNo
AmendedNo